Organon & Co. (OGN): Price and Financial Metrics

Organon & Co. (OGN): $14.58

0.14 (+0.97%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

OGN Price/Volume Stats

Current price $14.58 52-week high $23.10
Prev. close $14.44 52-week low $13.40
Day low $14.41 Volume 31,638,799
Day high $14.91 Avg. volume 2,445,023
50-day MA $16.16 Dividend yield 7.76%
200-day MA $19.03 Market Cap 3.75B

OGN Stock Price Chart Interactive Chart >


Organon & Co. (OGN) Company Bio


Organon & Co. Organon & Co. is a science-based global pharmaceutical company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Its women's health portfolio includes Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. Its operating segments include the Organon Products segment. The Organon Products segment is engaged in developing and delivering health solutions through its portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's products segment portfolio includes: Women's Health, Biosimilars and Established Brands. Women's Health contains contraception and fertility brands, such as Nexplanon or Implanon NXT, NuvaRing and elonva. The Company's Biosimilars portfolio consists of three immunology products: Brenzys, Renflexis and Hadlima; and two oncology products: Ontruzant and Aybintio.


OGN Latest News Stream


Event/Time News Detail
Loading, please wait...

OGN Latest Social Stream


Loading social stream, please wait...

View Full OGN Social Stream

OGN Price Returns

1-mo -4.58%
3-mo -24.53%
6-mo -27.06%
1-year 11.35%
3-year N/A
5-year N/A
YTD 7.41%
2023 -45.12%
2022 -4.86%
2021 N/A
2020 N/A
2019 N/A

OGN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full OGN Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!